Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3184.33 | 245 / 245 | 100% | 73.30 | 502 / 502 |
esophagus | 100% | 2421.27 | 1444 / 1445 | 100% | 27.48 | 183 / 183 |
breast | 100% | 2444.92 | 459 / 459 | 100% | 26.02 | 1116 / 1118 |
bladder | 100% | 1938.14 | 21 / 21 | 99% | 16.73 | 500 / 504 |
intestine | 100% | 1922.52 | 966 / 966 | 99% | 19.18 | 522 / 527 |
lung | 100% | 2745.93 | 576 / 578 | 99% | 17.05 | 1147 / 1155 |
stomach | 100% | 1685.90 | 358 / 359 | 99% | 18.74 | 283 / 286 |
uterus | 100% | 1804.59 | 170 / 170 | 98% | 18.24 | 451 / 459 |
thymus | 100% | 1730.79 | 651 / 653 | 98% | 12.51 | 595 / 605 |
pancreas | 98% | 1304.70 | 322 / 328 | 99% | 18.66 | 176 / 178 |
liver | 100% | 2295.40 | 226 / 226 | 95% | 15.28 | 387 / 406 |
kidney | 99% | 1059.85 | 88 / 89 | 93% | 12.43 | 839 / 901 |
skin | 100% | 5837.17 | 1809 / 1809 | 91% | 13.89 | 431 / 472 |
adrenal gland | 100% | 1622.11 | 258 / 258 | 87% | 7.77 | 201 / 230 |
ovary | 100% | 1541.22 | 180 / 180 | 86% | 7.45 | 369 / 430 |
brain | 78% | 624.31 | 2048 / 2642 | 98% | 11.33 | 689 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.93 | 29 / 29 |
spleen | 100% | 3094.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.72 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.86 | 1 / 1 |
adipose | 100% | 2224.79 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1533.22 | 1331 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4671.45 | 924 / 929 | 0% | 0 | 0 / 0 |
muscle | 99% | 1570.51 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 87% | 867.88 | 752 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 8.48 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001556 | Biological process | oocyte maturation |
GO_0071044 | Biological process | histone mRNA catabolic process |
GO_0031054 | Biological process | pre-miRNA processing |
GO_0071076 | Biological process | RNA 3' uridylation |
GO_1990074 | Biological process | polyuridylation-dependent mRNA catabolic process |
GO_0010586 | Biological process | miRNA metabolic process |
GO_0031123 | Biological process | RNA 3'-end processing |
GO_0141008 | Biological process | retrotransposon silencing by mRNA destabilization |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0050265 | Molecular function | RNA uridylyltransferase activity |
GO_0035198 | Molecular function | miRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0070569 | Molecular function | uridylyltransferase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | TUT7 |
Protein name | Terminal uridylyl transferase 7 ZCCHC6 protein Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6) RNA uridylyltransferase (EC 2.7.7.52) |
Synonyms | ZCCHC6 KIAA1711 HS2 |
Description | FUNCTION: Uridylyltransferase that mediates the terminal uridylation of mRNAs with short (less than 25 nucleotides) poly(A) tails, hence facilitating global mRNA decay . Essential for both oocyte maturation and fertility. Through 3' terminal uridylation of mRNA, sculpts, with TUT7, the maternal transcriptome by eliminating transcripts during oocyte growth (By similarity). Involved in microRNA (miRNA)-induced gene silencing through uridylation of deadenylated miRNA targets . Also functions as an integral regulator of microRNA biogenesiS using 3 different uridylation mechanisms . Acts as a suppressor of miRNA biogenesis by mediating the terminal uridylation of some miRNA precursors, including that of let-7 (pre-let-7). Uridylated pre-let-7 RNA is not processed by Dicer and undergo degradation. Pre-let-7 uridylation is strongly enhanced in the presence of LIN28A . In the absence of LIN28A, TUT7 and TUT4 monouridylate group II pre-miRNAs, which includes most of pre-let7 members, that shapes an optimal 3' end overhang for efficient processing . Add oligo-U tails to truncated pre-miRNAS with a 5' overhang which may promote rapid degradation of non-functional pre-miRNA species . Does not play a role in replication-dependent histone mRNA degradation . Due to functional redundancy between TUT4 and TUT7, the identification of the specific role of each of these proteins is difficult . TUT4 and TUT7 restrict retrotransposition of long interspersed element-1 (LINE-1) in cooperation with MOV10 counteracting the RNA chaperonne activity of L1RE1. TUT7 uridylates LINE-1 mRNAs in the cytoplasm which inhibits initiation of reverse transcription once in the nucleus, whereas uridylation by TUT4 destabilizes mRNAs in cytoplasmic ribonucleoprotein granules . . |
Accessions | ENST00000375960.6 [Q5VYS8-4] X6R3Q3 ENST00000375957.5 Q5VYT0 ENST00000375947.1 ENST00000277141.10 ENST00000375963.8 [Q5VYS8-1] Q5VYS8 Q5VYS9 ENST00000375948.2 A0A0C4DFW3 Q96KX5 |